Diabetes Information

Is Winter To Blame For Type 1 Diabetes?
Researchers from Finland have found a correlation between new cases of Type 1 diabetes and winter months. The study analysed data of 31,000 children from 105 diabetes centres across 53 countries found a correlation between the season and the onset of Type 1 diabetes. Of the 42 centres that exhibited this seasonal trend, 28 centres had peaks of diagnosis in winter and 33 had troughs in summer.

An Investigation Into The Immune Response To Wheat Offers A Clue To The Elusive Cause Of Type 1 Diabetes
Scientists at the Ottawa Hospital Research Institute and the University of Ottawa have discovered what may be an important clue to the cause of type 1 diabetes. Dr. Fraser Scott and his team tested 42 people with type 1 diabetes and found that nearly half had an abnormal immune response to wheat proteins. The study is published in the August 2009 issue of the journal Diabetes.

Is Winter To Blame For Type 1 Diabetes?
Researchers from Finland have found a correlation between new cases of Type 1 diabetes and winter months. The study analysed data of 31,000 children from 105 diabetes centres across 53 countries found a correlation between the season and the onset of Type 1 diabetes. Of the 42 centres that exhibited this seasonal trend, 28 centres had peaks of diagnosis in winter and 33 had troughs in summer.

Caregivers Of People With Diabetes: Diet And Exercise Plans, Managing Blood Sugar Levels And Reliable Online Information Cited As Top Concerns
The Hormone Foundation, the public education affiliate of The Endocrine Society, in collaboration with the National Alliance for Caregiving, released key findings from a first-of-its-kind survey aimed at better understanding the daily needs and struggles of unpaid caregivers of people with diabetes.

An 'Electronic Tongue' With A Taste For Sweets
In a new approach to an effective "electronic tongue" that mimics human taste, scientists in Illinois are reporting development of a small, inexpensive, lab-on-a-chip sensor that quickly and accurately identifies sweetness - one of the five primary tastes. It can identify with 100 percent accuracy the full sweep of natural and artificial sweet substances, including 14 common sweeteners, using easy-to-read color markers.

Does Sugar Feed Cancer? New Research Sheds Light On Old Saying
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have uncovered new information on the notion that sugar "feeds" tumors. The findings may also have implications for other diseases such as diabetes. The research is published in the journal Proceedings of the National Academy of Sciences (PNAS). "It's been known since 1923 that tumor cells use a lot more glucose than normal cells.

New Approach To Wound Healing May Be Easy On Skin, But Hard On Bacteria
In a presentation to the American Chemical Society meeting, Ankit Agarwal, a postdoctoral researcher at the University of Wisconsin-Madison, described an experimental approach to wound healing that could take advantage of silver's anti-bacterial properties, while sidestepping the damage silver can cause to cells needed for healing.

Survey Reveals Patients' Concerns About Diabetes Complications
The results of a Diabetes UK survey show that 80 per cent of those surveyed are concerned about having a heart attack, stroke or nerve damage; almost 50 per cent are concerned about experiencing hypoglycaemia; nearly 25 per cent have experienced sexual dysfunction; just under ten per cent have suffered eye damage; and eight per cent have cardiovascular disease. Diabetes UK conducted the survey with over 2,500 adults affected by Type 2 diabetes.

Does Sugar Feed Cancer? New Research Sheds Light On Old Saying
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have uncovered new information on the notion that sugar "feeds" tumors. The findings may also have implications for other diseases such as diabetes. The research is published in the journal Proceedings of the National Academy of Sciences (PNAS). "It's been known since 1923 that tumor cells use a lot more glucose than normal cells.

Efforts To Create Treatment Guidelines Are Often Complicated
The development of treatment guidelines for illnesses such as diabetes is a complicated process. The New York Times reports: "The goal [of creating guidelines] is to improve treatment and, at the same time, save money. But setting guidelines that are good for every patient... can get messy, with some experts warning that a big national plan of this sort poses risks.

GlycoMimetics, Inc. Awarded National Institutes of Health Grant To Study Drug Candidate In Diabetes
GlycoMimetics, Inc., a clinical-stage biotechnology company that is developing a new class of glycobiology-based therapies for a broad range of indications, announced it has been awarded a grant from The National Heart, Lung, and Blood Institute (NHLBI) of The National Institutes of Health (NIH) to evaluate its E-selectin small molecule antagonists in animal models of vascular complications of diabetes.

A Drug Used To Treat Type 2 Diabetes Is Associated To Increased Risk Of Heart Failure
A study just published on bmj.com reports that rosiglitazone, a drug used to treat type 2 diabetes, is linked with an increased risk of heart failure and death among elder patients compared to pioglitazone, which is a similar drug. As a result, the researchers point out it is questionable to support continued use of rosiglitazone for the majority of patients. Rosiglitazone and pioglitazone are part of a group of drugs called thiazolidinediones.

Healthy Lifestyle Reduces Risk Of Chronic Conditions
Researchers at the Centre for Disease Control and Prevention in Atlanta studied data from 25,513 adults aged 35 to 65. They found that never smoking, having a body mass index lower than 30, doing physical activity for at least three and a half hours per week, and following a healthy diet, reduce the risk of developing Type 2 diabetes by 93 percent.

Survey Reveals Patients' Concerns About Diabetes Complications
The results of a Diabetes UK survey show that 80 per cent of those surveyed are concerned about having a heart attack, stroke or nerve damage; almost 50 per cent are concerned about experiencing hypoglycaemia; nearly 25 per cent have experienced sexual dysfunction; just under ten per cent have suffered eye damage; and eight per cent have cardiovascular disease. Diabetes UK conducted the survey with over 2,500 adults affected by Type 2 diabetes.

Treating High Systolic Blood Pressure In Non-Diabetic Patients Could Be Beneficial
Treatment to lower high systolic blood pressure in non-diabetic patients is associated with a reduction in left ventricular hypertrophy (LVH), a thickening of the heart muscle that can lead to heart failure and rhythm problems. Thus, a lowering of systolic blood pressure targets from the currently recommended 140 mm/Hg or less to below 130 mm Hg should be the treatment goal in low-risk patients with high blood pressure, concludes an Article published in this week's edition of The Lancet.

More Fruits And Veggies, Less Salt Prevent Kidney Stones From Forming
Researchers have found another reason to eat well: a healthy diet helps prevent kidney stones. Loading up on fruits, vegetables, nuts, low-fat dairy products, and whole grains, while limiting salt, red and processed meats, and sweetened beverages is an effective way to ward off kidney stones, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN).

Primary Care Needs Of Those Living With HIV Highlighted By Updated Guidelines
With HIV patients living longer thanks to advances in treatment, the primary care needs of those living with HIV have never been more important. Updated, evidence-based guidelines from the HIV Medicine Association (HIVMA) and the Infectious Diseases Society of America (IDSA) are designed to help providers manage the care of those living with this complex chronic infection.

More Insulin-Producing Cells, At The Flip Of A 'Switch'
Researchers have found a way in mice to convert another type of pancreas cell into the critical insulin-producing beta cells that are lost in those with type I diabetes. The secret ingredient is a single transcription factor, according to the report in the August 7th issue of Cell, a Cell Press journal. When the gene called Pax4 is forced on in pancreatic alpha cells, the cells change their identity to become beta cells, the researchers found.

Innovative Diabetes Drug Discovery And Development Partnership Announced By JDRF And GNF
The Juvenile Diabetes Research Foundation has said that it has entered into a novel collaborative research agreement with the Genomics Institute of the Novartis Research Foundation (GNF) to create a diabetes drug discovery and development platform. The four-year program is one of the largest and most comprehensive collaborations in the 40 year history of JDRF, a leader in setting the agenda for diabetes research worldwide and the largest charitable funder and advocate of type 1 research.

Supporting Research On Age-Related Diseases And Clinical Care
The American Federation for Aging Research (AFAR), The National Institute on Aging (NIA), The Atlantic Philanthropies, The John A. Hartford Foundation, The Starr Foundation and other program partners are pleased to announce the 2009 recipients of the Paul B. Beeson Career Development Awards in Aging Research Program.

Radiation Therapy May Increase Diabetes Risk In Childhood Cancer Survivors
Childhood cancer survivors treated with total body or abdominal radiation may have an increased risk of diabetes, according to a report in the August 10/24 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. This correlation does not appear to be related to patients' body mass index or physical inactivity.

Bayer Statement On U.S. Food And Drug Administration Advice For Patients: Serious Errors With Certain Blood Glucose Monitoring Test Strips
Since 2006, Bayer Diabetes Care has not distributed test strips that use GDH-PQQ (glucose dehydrogenase pyrroloquinoline quinone) glucose monitoring technology for its blood glucose meters. As referenced in a U.S. Food and Drug Administration Advice for Diabetic Patients and their Caregivers issued today, blood glucose meters that use GDH-PQQ technology may "produce a falsely high (elevated) blood glucose result.

Reducing Cardiovascular Events: International Insulin Drug Trial
Accumulating safety data from the large, international ORIGIN trial have been reviewed by its independent data monitoring committee, who have concluded that there is no cause for concern. This six-year study, which is lead by McMaster University professors Dr. Hertzel Gerstein and Dr.

More Fruits And Veggies, Less Salt Prevent Kidney Stones From Forming
Researchers have found another reason to eat well: a healthy diet helps prevent kidney stones. Loading up on fruits, vegetables, nuts, low-fat dairy products, and whole grains, while limiting salt, red and processed meats, and sweetened beverages is an effective way to ward off kidney stones, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN).

Diabetes: MRI May Help In The Diagnosis, Staging And Treatment
Noninvasive imaging (MRI) may aid physicians in the early diagnosis, staging and treatment of diabetes, according to a study performed at Massachusetts General Hospital and Harvard Medical School in Boston, MA. This is the first study of its kind to apply noninvasive imaging techniques to diabetes research.

Rush University Medical Center Hosts Conference Examining Chicago Breastfeeding Rates And Ways To Reduce The Disparities
Over 100 certified breastfeeding peer counselors, lactation consultants, nurses, physicians, dietitians and community health workers are expected to gather at Rush University Medical Center on Thursday, August 6 from 8 a.m. until 1 p.m. in Room 500 at 1725 W. Harrison Street, Chicago, to attend the Griffin Inaugural Conference on Breastfeeding: The Primary Foundation for Health.

Array BioPharma Reports Positive Results Of Its Oral Glucokinase Activator In Type 2 Diabetes Patients
Array BioPharma Inc. announced yesterday positive top-line data from a Phase 1 clinical trial in patients with Type 2 diabetes with its novel small molecule glucokinase activator (GKA), ARRY-403. The drug met its primary and secondary endpoints of safety, pharmacokinetics and glucose control. ARRY-403 was evaluated in a Phase 1 single ascending dose study.

Stimulus Funding Helps K-State Biochemist Study Eye's Lens In Diabetes, Galactosemia Patients
Thanks to a grant awarded through federal stimulus research funding, a Kansas State University biochemist has more funding for research that could eventually help diabetics preserve their eyesight. Dolores Takemoto, a K-State professor of biochemistry, received more than $366,000 from the National Eye Institute to study how a particular enzyme affects the lens.

Association Between Subjective Symptoms Of Sleep Quality, Daytime Sleepiness And Declining Quality Of Life
A study, "Longitudinal Evaluation of Sleep-Disordered Breathing and Sleep Symptoms with Change in Quality of Life: The Sleep Heart Health Study (SHHS)," in the Aug. 1 issue of the journal Sleep indicates that self-reported worsening in initiating and maintaining sleep over a five-year period was significantly associated with poorer mental quality of life, and increasing daytime sleepiness symptoms were associated with both poorer physical and mental quality of life.

Joslin Study Identifies Gene Linked To Rare Form Of Diabetes
Researchers at the Joslin Diabetes Center have linked another gene to a rare form of diabetes, a finding that could prove beneficial to those with the more common type 2 diabetes. In a study published this week in Proceedings of the National Academy of Sciences Early Edition, a team led by Alessandro Doria, M.D., Ph.D. and Rohit N. Kulkarni, M.D., Ph.D.

Innovative Diabetes Drug Discovery And Development Partnership Announced By JDRF And GNF
The Juvenile Diabetes Research Foundation has said that it has entered into a novel collaborative research agreement with the Genomics Institute of the Novartis Research Foundation (GNF) to create a diabetes drug discovery and development platform. The four-year program is one of the largest and most comprehensive collaborations in the 40 year history of JDRF, a leader in setting the agenda for diabetes research worldwide and the largest charitable funder and advocate of type 1 research.

Innovative Diabetes Drug Discovery And Development Partnership Announced By JDRF And GNF
The Juvenile Diabetes Research Foundation has said that it has entered into a novel collaborative research agreement with the Genomics Institute of the Novartis Research Foundation (GNF) to create a diabetes drug discovery and development platform. The four-year program is one of the largest and most comprehensive collaborations in the 40 year history of JDRF, a leader in setting the agenda for diabetes research worldwide and the largest charitable funder and advocate of type 1 research.

Rates Of Severe Childhood Obesity Have Tripled
Rates of severe childhood obesity have tripled in the last 25 years, putting many children at risk for diabetes and heart disease, according to a report in Academic Pediatrics by an obesity expert at Brenner Children's Hospital, part of Wake Forest University Baptist Medical Center. "Children are not only becoming obese, but becoming severely obese, which impacts their overall health," said Joseph Skelton, M.D.

Rush University Medical Center Hosts Conference Examining Chicago Breastfeeding Rates And Ways To Reduce The Disparities
Over 100 certified breastfeeding peer counselors, lactation consultants, nurses, physicians, dietitians and community health workers are expected to gather at Rush University Medical Center on Thursday, August 6 from 8 a.m. until 1 p.m. in Room 500 at 1725 W. Harrison Street, Chicago, to attend the Griffin Inaugural Conference on Breastfeeding: The Primary Foundation for Health.

More Insulin-Producing Cells, At The Flip Of A 'Switch'
Researchers have found a way in mice to convert another type of pancreas cell into the critical insulin-producing beta cells that are lost in those with type I diabetes. The secret ingredient is a single transcription factor, according to the report in the August 7th issue of Cell, a Cell Press journal. When the gene called Pax4 is forced on in pancreatic alpha cells, the cells change their identity to become beta cells, the researchers found.

Diabetes UK Fundraiser On Trafalgar Square's Fourth Plinth
Richard Chapman, from Selsdon, near Croydon, stood on Trafalgar Square's Fourth Plinth yesterday from 9pm to 10pm to raise funds and awareness for Diabetes UK. The Fourth Plinth in Trafalgar Square, London, is the central part of an art project by Antony Gormley. Called 'One and Other', the project sees a different person, selected randomly from a pool of thousands, stand on the plinth for an hour, every day, 24 hours a day, for 100 days.

Online Diabetes Service To Connect People With Clinical Trial Information
The Juvenile Diabetes Research Foundation, a leader in setting the agenda for diabetes research worldwide and the largest charitable funder and advocate of type 1 research, has announced that it has launched an on-line service for people with type 1 diabetes and their families to easily find information about clinical trials for drugs, treatments, and therapeutics for diabetes and its complications.

Gut Hormone Has 'Remote Control' On Blood Sugar
A gut hormone first described in 1928 plays an unanticipated and important role in the remote control of blood sugar production in the liver, according to a report in the August 6th Cell Metabolism, a Cell Press publication. What's more, the researchers show that rats fed a high-fat diet for a few days become resistant to the glucose-lowering hormone known as cholecystokinin (CCK).

Gut Hormone Has 'Remote Control' On Blood Sugar
A gut hormone first described in 1928 plays an unanticipated and important role in the remote control of blood sugar production in the liver, according to a report in the August 6th Cell Metabolism, a Cell Press publication. What's more, the researchers show that rats fed a high-fat diet for a few days become resistant to the glucose-lowering hormone known as cholecystokinin (CCK).

Cancer Treatment Controls Macular Edema Related To Diabetes And To Cataract Surgery
This month's Ophthalmology, the journal of the American Academy of Ophthalmology, reports on the use of bevacizumab (Avastin) to benefit diabetic patients with macular edema as well as people who develop cystoid macular edema after cataract surgery. Bevacizumab is also used to treat some cancers. A third study describes methods that could make cataract surgery safer for

Food Additive May One Day Help Control Blood Lipids And Reduce Disease Risk
Scientists at Washington University School of Medicine in St. Louis have identified a substance in the liver that helps process fat and glucose. That substance is a component of the common food additive lecithin, and researchers speculate it may one day be possible to use lecithin products to control blood lipids and reduce risk for diabetes, hypertension or cardiovascular disease using treatments delivered in food rather than medication.

U.S. Food And Drug Administration Approves ONGLYZA™ (saxagliptin) For The Treatment Of Type 2 Diabetes Mellitus In Adults
Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) announced that the U.S. Food and Drug Administration (FDA) approved ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor. ONGLYZA is indicated as an adjunct to diet and exercise to improve blood sugar (glycemic) control in adults for the treatment of type 2 diabetes mellitus.

From Molecular Physiology To Therapeutic Applications Of Stem Cells
Stem cell research promises remedies to many devastating diseases that are currently incurable, ranging from diabetes and Parkinson's disease to paralysis. Totipotent embryonic stem cells have great potential for generating a wide range of different human cells that can be used to restore malfunctioning or damaged cells and tissues in patients.

New Powder Speeds Healing Of Difficult Foot Wounds
Foot complications, such as open wounds and ulcers, can be one of the most difficult ailments for a podiatrist to treat. However, a new wound dressing powder, which acts very much like a layer of skin, is proving to speed the healing time and reduce the amount of pain that a patient suffering from a serious foot ulcer would normally experience. This includes open sores on the feet as a result of inflammatory bowel disease, diabetes or skin cancer.

Cardium Provides Update On Phase 2b Excellarate Clinical Study And Plans For Additional Tissue Repair Applications
Cardium Therapeutics (NYSE Amex: CXM) and its subsidiary Tissue Repair Company (TRC) provided an update on the completion of their MATRIX Phase 2b clinical study and announced plans to provide detailed safety and efficacy data for their Excellarate(TM) product candidate around the end of September. The MATRIX trial, a prospective, randomized, double-blind, placebo-controlled study, has enrolled 124 diabetic patients with non-healing, lower extremity neuropathic ulcers.

International Diabetes Federation Launch Landmark Action Plan To Tackle Rising Diabetes Epidemic In Africa
The International Diabetes Federation African Region (IDF Africa) launched a critical action plan today to address the escalating threat that diabetes poses to the region. The plan identifies three key areas of action: government, primary healthcare and the community, defining a clear step-based strategy for tackling diabetes and implementing the UN Resolution on diabetes in Africa.

Common Diabetic Therapy Reduces Risk Of Pancreatic Cancer
Taking the most commonly-prescribed anti-diabetic drug, metformin, reduces an individual's risk of developing pancreatic cancer by 62 percent, according to research from The University of Texas M. D. Anderson Cancer Center, published in the Aug. 1 issue of Gastroenterology.

IgM In Urine Acts As Prognostic Indicator In Diabetes
A marker of the likely course of diabetic nephropathy (DN) has been found. An 18-year study, published in the open access journal BMC Medicine, has shown that Immunoglobulin M (IgM) is a reliable predictor of cardiovascular complications in DN patients. Omran Bakoush, MD, PhD, led a team of researchers from Lund University, Sweden, who carried out the research.

Rates Of Severe Childhood Obesity Have Tripled
Rates of severe childhood obesity have tripled in the last 25 years, putting many children at risk for diabetes and heart disease, according to a report in Academic Pediatrics by an obesity expert at Brenner Children's Hospital, part of Wake Forest University Baptist Medical Center. "Children are not only becoming obese, but becoming severely obese, which impacts their overall health," said Joseph Skelton, M.D.

International Diabetes Federation Launch Landmark Action Plan To Tackle Rising Diabetes Epidemic In Africa
The International Diabetes Federation African Region (IDF Africa) launched a critical action plan today to address the escalating threat that diabetes poses to the region. The plan identifies three key areas of action: government, primary healthcare and the community, defining a clear step-based strategy for tackling diabetes and implementing the UN Resolution on diabetes in Africa.

International Diabetes Federation Launch Landmark Action Plan To Tackle Rising Diabetes Epidemic In Africa
The International Diabetes Federation African Region (IDF Africa) launched a critical action plan today to address the escalating threat that diabetes poses to the region. The plan identifies three key areas of action: government, primary healthcare and the community, defining a clear step-based strategy for tackling diabetes and implementing the UN Resolution on diabetes in Africa.

Cancer Treatment Controls Macular Edema Related To Diabetes And To Cataract Surgery
This month's Ophthalmology, the journal of the American Academy of Ophthalmology, reports on the use of bevacizumab (Avastin) to benefit diabetic patients with macular edema as well as people who develop cystoid macular edema after cataract surgery. Bevacizumab is also used to treat some cancers. A third study describes methods that could make cataract surgery safer for

U.S. Food And Drug Administration Approves ONGLYZA™ (saxagliptin) For The Treatment Of Type 2 Diabetes Mellitus In Adults
Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) announced that the U.S. Food and Drug Administration (FDA) approved ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor. ONGLYZA is indicated as an adjunct to diet and exercise to improve blood sugar (glycemic) control in adults for the treatment of type 2 diabetes mellitus.

Diabetes Gene Raises Odds Of Lower Birth Weight
Pediatric researchers have found that a gene previously shown to be involved in the development of type 2 diabetes also predisposes children to having a lower birth weight. The finding sheds light on a possible genetic influence on how prenatal events may set the stage for developing diabetes in later childhood or adulthood.

American Diabetes Association Launches My Health Advisor -- Online Calculator That Shows Risk For Diabetes, Heart Disease And Stroke
With an estimated 57 million Americans with pre-diabetes, the American Diabetes Association today launches My Health Advisor, an online tool that helps people understand their personal risk for developing type 2 diabetes, heart disease and stroke. My Health Advisor is available at http://www.CheckUpAmerica.org/MHA.

U.S. Food And Drug Administration Approves ONGLYZA™ (saxagliptin) For The Treatment Of Type 2 Diabetes Mellitus In Adults
Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) announced that the U.S. Food and Drug Administration (FDA) approved ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor. ONGLYZA is indicated as an adjunct to diet and exercise to improve blood sugar (glycemic) control in adults for the treatment of type 2 diabetes mellitus.

Online Diabetes Service To Connect People With Clinical Trial Information
The Juvenile Diabetes Research Foundation, a leader in setting the agenda for diabetes research worldwide and the largest charitable funder and advocate of type 1 research, has announced that it has launched an on-line service for people with type 1 diabetes and their families to easily find information about clinical trials for drugs, treatments, and therapeutics for diabetes and its complications.

What Does Quality Of Life Mean To You?
Lifepsychol is a new healthcare initiative designed to focus attention on ways to support and improve the quality of life of people with long term conditions. Lifepsychol is conducting a survey to learn what people mean from the term 'quality of life'. In healthcare, this can mean a person's emotional, physical and mental wellbeing, and their general ability to function as an individual.

Wiley-Blackwell To Publish Journal Of Diabetes Investigation
Wiley-Blackwell, the scientific, technical, medical and scholarly publishing business of John Wiley & Sons, Inc (NYSE: JWa), (NYSE: JWb), has announced that it will be publishing a new diabetes journal titled Journal of Diabetes Investigation from 2010.

Iron-Binding Drug Could Help Diabetics Heal Stubborn Wounds, Says Stanford/Einstein Study
A drug used to remove iron from the body could help doctors fight one of diabetes' cruelest complications: poor wound healing, which can lead to amputation of patients' toes, feet and even legs. The drug, deferoxamine, helped diabetic mice heal small cuts 10 days faster than those who did not receive treatment, according to researchers from Stanford University School of Medicine and the Albert Einstein College of Medicine.

Follow-Up Study Further Reinforces The Long-Term Benefits Of Tight Glucose Control In Early Treatment Of Diabetes
A study published in today's issue of the Archives of Internal Medicine provides further reinforcement that tight control of blood glucose as soon as possible after a diagnosis of type 1 diabetes yields long-term benefits with regard to lowering the rates of eye, kidney and heart complications associated with diabetes.

Diabetes Gene Raises Odds Of Lower Birth Weight
Pediatric researchers have found that a gene previously shown to be involved in the development of type 2 diabetes also predisposes children to having a lower birth weight. The finding sheds light on a possible genetic influence on how prenatal events may set the stage for developing diabetes in later childhood or adulthood.

Follow-Up Study Further Reinforces The Long-Term Benefits Of Tight Glucose Control In Early Treatment Of Diabetes
A study published in today's issue of the Archives of Internal Medicine provides further reinforcement that tight control of blood glucose as soon as possible after a diagnosis of type 1 diabetes yields long-term benefits with regard to lowering the rates of eye, kidney and heart complications associated with diabetes.

Antipsychotic Drugs Associated With High Blood Sugar In Older Adults With Diabetes
Older patients with diabetes who take antipsychotic medications appear to have an increased risk of hospitalization for hyperglycemia (elevated blood glucose level), especially soon after beginning treatment, according to a report in the July 27 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Researcher Offers Hope For Male Diabetes Sufferers - Hereditary Diabetes Insipidus
Scientists at Glasgow have made a significant discovery in the study of a rare form of diabetes which predominantly affects men. Hereditary Diabetes Insipidus is, according to experts, the most common genetic disease known in medicine. It causes serious kidney malfunction and can, if untreated, be fatal. There are an estimated to be around 9000 Heredirary DI patients in the UK.

Researchers To Inject People With Diabetes With Cells From Pigs
Researchers are hoping that cells from pigs from a remote group of islands 300 miles from New Zealand could lead to a new treatment for Type 1 diabetes. Some of the pigs have been moved from the islands to mainland New Zealand, where they are being kept in fully enclosed sterile housing. The scientists are trialling the cell transplantation technique on a small group of people with unstable Type 1 diabetes in the hope of stimulating insulin production in their pancreases.

Last Chance For PCTs To Take Part In Groundbreaking User Involvement Project, UK
Following the announcement that Diabetes UK and NHS Diabetes have joined forces to deliver an innovative project that will support three PCTs in England to develop effective user involvement approaches in diabetes care, the charity has received an excellent response from PCTs wanting to get involved. In order to meet the demand, Diabetes UK has decided to extend the deadline for initial expressions of interest to take part in the project from 31 July to the 7 August.

Oramed Pharmaceuticals Reports Positive Results From A Study Of Oral Insulin Capsule On Type 1 Diabetic Patients
Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB), a developer of alternative drug delivery systems, today reported positive results from a Phase 2A study of its oral insulin capsule, ORMD-0801, on type 1 diabetic patients. The completion of this study marks Oramed's first clinical trial on patients with Type 1 Diabetes Mellitus, whereas, all Oramed's trials up to date have been conducted on type 2 diabetic patients.

Advances In Lab-Grown Motor Nerves Can Lead To Cures For Diabetic Neuropathy And Help Further Understand Multiple Sclerosis And Related Conditions
In the July issue of Biomaterials, published by Elsevier, researchers from the University of Central Florida (UCF) report on the first lab-grown motor nerves that are insulated and organized just like they are in the human body. The model system will drastically improve understanding of the causes of myelin-related conditions, such as diabetic neuropathy and later, possibly multiple sclerosis (MS).

Diabetes UK Wants To Hear About Your Diabetes Experiences
Diabetes UK is looking for people with diabetes to share their experiences of supported self-management to help with our campaign for World Diabetes Day (14 November). As 95 per cent of diabetes care is through self-management, this key issue is one of Diabetes UK's priorities. It is about enabling people with diabetes to have the confidence and skills to better manage their lives with diabetes.

What Is Gangrene? What Causes Gangrene?
Gangrene occurs when tissue dies (necrosis) because its blood supply is interrupted. Gangrene may be caused by an infection, injury, or a complication of a long-term condition that restricts blood circulation. It most commonly occurs in the extremities - the toes, fingers, arms and legs - but internal organs and muscles may also become gangrenous. There are five main types of gangrene: 1. Dry gangrene. 2. Wet gangrene. 3. Gas gangrene. 4. Internal gangrene. 5. Fournier's gangrene.

Larry King Talks About His Diabetes For The First Time
Broadcasting legend Larry King turns the tables to talk about himself in his new autobiography, "My Remarkable Journey," but doesn't mention the chronic disease he's lived with for nearly fifteen years: type 2 diabetes. In an interview with

Diabetes Educators Get First Taste Of Nevella(R) With Probiotics, The Only Sweetener Designed To Boost The Immune System
Designed to boost the immune system and promote health, probiotics are gaining popularity at the grocery, and Nevella® with Probiotics, made by Heartland Sweeteners, is the first and only such sweetener currently on the market. Diabetes educators will get an early preview of Nevella® with Probiotics at their annual conference in Atlanta in early August, immediately prior to widespread availability across the country.

Grapefruit Ingredient - A Future Treatment For Type 2 Diabetes?
A team of Canadian scientists have discovered that naringenin, a flavonoid found in citrus fruit, and especially grapefruit, makes the liver burn fat instead of storing it after a meal. (This chemical compound also gives grapefruit its bitter taste.) Potentially, without having to change diets or cut out particular foods, a dose of naringenin could prevent weight gain and even help to lose it.

Trinity Biotech Announces TRI-statTM CLIA Submission To FDA
Trinity Biotech plc (NASDAQ: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, announced it has submitted its CLIA application for its TRI-stat™ point-of-care HbA1c product to the FDA. TRI-stat™ is designed to measure HbA1c, also known as glycated hemoglobin, a measure of a patient's average blood sugar control over the last two to three months.

OneTouch(R) Ping™ Glucose Management System Approved By Health Canada
Animas Corporation announcedthe approval of its OneTouch® Ping™ Glucose Management System by Health Canada. OneTouch Ping is the first full-feature insulin pump that wirelessly communicates with a blood glucose meter-remote. Using the OneTouch Ping meter-remote, a person can calculate insulin doses and opt to wirelessly instruct the pump to deliver them without touching the pump at all, giving patients more freedom and flexibility in using their insulin pump.

FDA Approves NovoLog(R) Labeling Update - Increasing The Time Patients Can Use And Store NovoLog(R) In Their Pumps From Two Days To Six Days
Diabetes patients taking NovoLog® (insulin aspart [rDNA origin] injection) can now use the insulin in their pump for up to six days following the U.S. Food and Drug Administration (FDA) approval of a labeling change, diabetes care company Novo Nordisk announced today.[i] The previous label allowed for NovoLog® to be stored in the pump reservoir for two days. This makes NovoLog® the first and only rapid-acting insulin with this extended in-use time.

Halozyme Begins Phase 2 Clinical Trial Of Insulin-PH20 In Type 2 Diabetic Patients
Halozyme Therapeutics, Inc. (Nasdaq:HALO) today announced the commencement of patient dosing in a Phase 2 clinical study of Insulin-PH20 in patients with Type 2 Diabetes Mellitus. This randomized cross-over design study is designed to compare the postprandial glycemic excursions following a standardized test meal after treatment with either insulin lispro+PH20 or regular insulin+PH20 relative to treatment with lispro (Humalog) alone.

Yale Discovery May Open Door To Drug That Cuts Appetite And Boosts Energy
In a major advance in obesity and diabetes research, Yale School of Medicine scientists have found that reducing levels of a key enzyme in the brain decreased appetites and increased energy levels. Reductions in the levels of the enzyme prolylcarboxypeptidase (PRCP) led to weight loss and a decreased risk of type 2 diabetes in mice, according to research published in the August issue of The Journal of Clinical Investigation.

Reliv International's GlucAffect(TM) Proven Effective In Clinical Study
A clinical study published in the journal Phytotherapy Research found that GlucAffect, a nutritional supplement developed by Reliv International, Inc. (Nasdaq: RELV), significantly reduced blood glucose levels and helped control weight in study participants. The study included 50 overweight individuals who had pre-diabetic glucose levels prior to the study.

Expert Statement Issued About Lantus(R) Following Recent Publications In Diabetologia
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced the release of an Expert Statement by a multidisciplinary board of renowned international experts following an in-depth assessment of the recent publications of registry analyses with Lantus(R) (insulin glargine [rDNA] injection) in Diabetologia.

OneTouch(R) Ping™ Glucose Management System Approved By Health Canada
Animas Corporation announcedthe approval of its OneTouch® Ping™ Glucose Management System by Health Canada. OneTouch Ping is the first full-feature insulin pump that wirelessly communicates with a blood glucose meter-remote. Using the OneTouch Ping meter-remote, a person can calculate insulin doses and opt to wirelessly instruct the pump to deliver them without touching the pump at all, giving patients more freedom and flexibility in using their insulin pump.

New Blood Glucose Meter Connects To Gaming Systems
A new blood glucose monitor, unveiled today, connects directly to Nintendo DST and Nintendo DST Lite gaming systems and was designed specifically for children with diabetes. The Didget meter aims to encourage children to build good blood glucose testing habits by awarding points that children can use to unlock new game levels and customise their gaming experience.

FDA Approves NovoLog(R) Labeling Update
Diabetes patients taking NovoLog((R)) (insulin aspart [rDNA origin] injection) can now use the insulin in their pump for up to six days following the U.S. Food and Drug Administration (FDA) approval of a labeling change, diabetes care company Novo Nordisk announced today.(1) The previous label allowed for NovoLog((R)) to be stored in the pump reservoir for two days. This makes NovoLog((R)) the first and only rapid-acting insulin with this extended in-use time.

Young Black Women Prone To Gain More Unhealthy Abdominal Fat Than Hispanics
Black women ages 20 to 29 are more prone to pack on unhealthy abdominal and visceral fat than Hispanic women the same age, and as compared to their elders, according to researchers from Wake Forest University Baptist Medical Center and colleagues. The new research shows that accumulation of abdominal fat that increases risk of type 2 diabetes is greatest in young adulthood for blacks and Hispanics, said endocrinologist Kristen G. Hairston, M.D., M.P.H.

Reliv International's GlucAffect(TM) Proven Effective In Clinical Study
A clinical study published in the journal Phytotherapy Research found that GlucAffect, a nutritional supplement developed by Reliv International, Inc. (Nasdaq: RELV), significantly reduced blood glucose levels and helped control weight in study participants. The study included 50 overweight individuals who had pre-diabetic glucose levels prior to the study.

New Role Discovered For Molecule Important In Development Of The Pancreas
For years researchers have been searching for a way to treat diabetics by reactivating their insulin-producing beta cells, to no avail. Now, they may be one step closer. A protein, whose role in pancreatic development has long been recognized, has been discovered to play an additional and previously unknown regulatory role in the development of cells in the immature endocrine system. These cells ultimately give rise to pancreatic islet cells, which include beta cells.

OneTouch(R) Ping™ Glucose Management System Approved By Health Canada
Animas Corporation announcedthe approval of its OneTouch® Ping™ Glucose Management System by Health Canada. OneTouch Ping is the first full-feature insulin pump that wirelessly communicates with a blood glucose meter-remote. Using the OneTouch Ping meter-remote, a person can calculate insulin doses and opt to wirelessly instruct the pump to deliver them without touching the pump at all, giving patients more freedom and flexibility in using their insulin pump.

Medtronic Voluntarily Recalls Specific Lots Of Paradigm(R) Quick-Set(R) Infusion Sets In The United States
Medtronic, Inc. (NYSE:MDT) said that it has initiated a recall of specific lots of Quick-set® infusion sets that are used with MiniMed Paradigm insulin pumps. An infusion set is a thin plastic tube used to deliver insulin from an insulin pump to a diabetes patient, and is typically replaced by the patient every three days. Affected infusion sets are reference numbers MMT-396, MMT-397, MMT-398 and MMT-399 with lot numbers starting with the number "8.

FDA Approves NovoLog(R) Labeling Update - Increasing The Time Patients Can Use And Store NovoLog(R) In Their Pumps From Two Days To Six Days
Diabetes patients taking NovoLog® (insulin aspart [rDNA origin] injection) can now use the insulin in their pump for up to six days following the U.S. Food and Drug Administration (FDA) approval of a labeling change, diabetes care company Novo Nordisk announced today.[i] The previous label allowed for NovoLog® to be stored in the pump reservoir for two days. This makes NovoLog® the first and only rapid-acting insulin with this extended in-use time.

Echo Therapeutics To Present At Prestigious 'Innovations In Diabetes' Conference
Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a diabetes management company developing the needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system, announced that Patrick T. Mooney, M.D., Chairman and Chief Executive Officer, will present at the "Innovations in Diabetes" Conference on, Tuesday, July 14, 2009 at 5:30 pm ET.

Grapefruit Ingredient - A Future Treatment For Type 2 Diabetes?
A team of Canadian scientists have discovered that naringenin, a flavonoid found in citrus fruit, and especially grapefruit, makes the liver burn fat instead of storing it after a meal. (This chemical compound also gives grapefruit its bitter taste.) Potentially, without having to change diets or cut out particular foods, a dose of naringenin could prevent weight gain and even help to lose it.

FDA Approves NovoLog(R) Labeling Update
Diabetes patients taking NovoLog((R)) (insulin aspart [rDNA origin] injection) can now use the insulin in their pump for up to six days following the U.S. Food and Drug Administration (FDA) approval of a labeling change, diabetes care company Novo Nordisk announced today.(1) The previous label allowed for NovoLog((R)) to be stored in the pump reservoir for two days. This makes NovoLog((R)) the first and only rapid-acting insulin with this extended in-use time.

Expert Statement Issued About Lantus(R) Following Recent Publications In Diabetologia
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced the release of an Expert Statement by a multidisciplinary board of renowned international experts following an in-depth assessment of the recent publications of registry analyses with Lantus(R) (insulin glargine [rDNA] injection) in Diabetologia.

Halozyme Begins Phase 2 Clinical Trial Of Insulin-PH20 In Type 2 Diabetic Patients
Halozyme Therapeutics, Inc. (Nasdaq:HALO) today announced the commencement of patient dosing in a Phase 2 clinical study of Insulin-PH20 in patients with Type 2 Diabetes Mellitus. This randomized cross-over design study is designed to compare the postprandial glycemic excursions following a standardized test meal after treatment with either insulin lispro+PH20 or regular insulin+PH20 relative to treatment with lispro (Humalog) alone.

New Blood Glucose Meter Connects To Gaming Systems
A new blood glucose monitor, unveiled today, connects directly to Nintendo DST and Nintendo DST Lite gaming systems and was designed specifically for children with diabetes. The Didget meter aims to encourage children to build good blood glucose testing habits by awarding points that children can use to unlock new game levels and customise their gaming experience.

New Blood Glucose Meter Connects To Gaming Systems
A new blood glucose monitor, unveiled today, connects directly to Nintendo DST and Nintendo DST Lite gaming systems and was designed specifically for children with diabetes. The Didget meter aims to encourage children to build good blood glucose testing habits by awarding points that children can use to unlock new game levels and customise their gaming experience.

News From The Annals Of Family Medicine: July/August 2009
The Primary Care Paradox and the Need to Integrate Primary and Specialty Care to Improve the Quality of Healthcare The third in a seven-part series of commentaries to understand health and healthcare With the healthcare reform debate heating up in Washington, D.C., Annals of Family Medicine editor Kurt Stange, M.D., Ph.D.

Scientists Step Closer To Helping Diabetics Regenerate Insulin Making Cells
US scientists have come a step closer to finding a way to help treat people with diabetes by reactivating their own insulin-producing beta cells in the pancreas, although they acknowledge that this goal is still a long way off. They discovered a hitherto unknown role for a well known protein: it helps immature endocrine systems generate new pancreatic islet cells, which include the insulin-producing beta cells.

Scientists Step Closer To Helping Diabetics Regenerate Insulin Making Cells
US scientists have come a step closer to finding a way to help treat people with diabetes by reactivating their own insulin-producing beta cells in the pancreas, although they acknowledge that this goal is still a long way off. They discovered a hitherto unknown role for a well known protein: it helps immature endocrine systems generate new pancreatic islet cells, which include the insulin-producing beta cells.

News From The Annals Of Family Medicine: July/August 2009
The Primary Care Paradox and the Need to Integrate Primary and Specialty Care to Improve the Quality of Healthcare The third in a seven-part series of commentaries to understand health and healthcare With the healthcare reform debate heating up in Washington, D.C., Annals of Family Medicine editor Kurt Stange, M.D., Ph.D.

Scientists Step Closer To Helping Diabetics Regenerate Insulin Making Cells
US scientists have come a step closer to finding a way to help treat people with diabetes by reactivating their own insulin-producing beta cells in the pancreas, although they acknowledge that this goal is still a long way off. They discovered a hitherto unknown role for a well known protein: it helps immature endocrine systems generate new pancreatic islet cells, which include the insulin-producing beta cells.

Scientists Step Closer To Helping Diabetics Regenerate Insulin Making Cells
US scientists have come a step closer to finding a way to help treat people with diabetes by reactivating their own insulin-producing beta cells in the pancreas, although they acknowledge that this goal is still a long way off. They discovered a hitherto unknown role for a well known protein: it helps immature endocrine systems generate new pancreatic islet cells, which include the insulin-producing beta cells.

New Role Discovered For Molecule Important In Development Of The Pancreas
For years researchers have been searching for a way to treat diabetics by reactivating their insulin-producing beta cells, to no avail. Now, they may be one step closer. A protein, whose role in pancreatic development has long been recognized, has been discovered to play an additional and previously unknown regulatory role in the development of cells in the immature endocrine system. These cells ultimately give rise to pancreatic islet cells, which include beta cells.

Eating Fewer Calories Linked To Delayed Disease And Longer Life, Animal Study
US scientists found that when rhesus monkeys were kept on a nutritious but reduced calorie diet for 20 years they led a longer and healthier life with delayed onset of diseases of aging such as cancer, diabetes, cardiovascular disease and brain atrophy.

Echo Therapeutics To Present At Prestigious 'Innovations In Diabetes' Conference
Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a diabetes management company developing the needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system, announced that Patrick T. Mooney, M.D., Chairman and Chief Executive Officer, will present at the "Innovations in Diabetes" Conference on, Tuesday, July 14, 2009 at 5:30 pm ET.

ECOSOC's Agenda Should Include Noncommunicable Disease Threat In Developing Countries
"[E]xplicit indicators to measure progress in reducing heart diseases, stroke, diabetes, cancers and chronic respiratory diseases" are missing from the U.N.

Wanted - PCTs To Get Involved In Groundbreaking User Involvement Project, UK
Diabetes UK and NHS Diabetes have joined forces to deliver an innovative project that will support three primary care trusts (PCTs) in England to develop effective user involvement approaches in diabetes care. The charity is now seeking three organisations to become our local partners.

Higher Levels Of A Certain Protein Associated With Lower Risk Of Type 2 Diabetes
Persons with higher levels of adiponectin, a protein that is produced by fat cells and that has anti-inflammatory and insulin-sensitizing properties, have an associated lower risk of type 2 diabetes, according to an analysis of previous studies, reported in the July 8 issue of JAMA.

Scientists Link Elevated Insulin To Increased Breast Cancer Risk
Elevated insulin levels in the blood appear to raise the risk of breast cancer in postmenopausal women, according to researchers at Albert Einstein College of Medicine of Yeshiva University. Their findings are published in the online version of the International Journal of Cancer. Increased breast cancer risk for postmenopausal women has previously been linked to obesity and diabetes.

Researchers Find Possible Environmental Causes For Alzheimer's, Diabetes
A new study by researchers at Rhode Island Hospital have found a substantial link between increased levels of nitrates in our environment and food, with increased deaths from diseases, including Alzheimer's, diabetes mellitus and Parkinson's. The study was published in the Journal of Alzheimer's Disease (Volume 17:3 July 2009).

Do You Know Someone Eligible For A Diabetes UK Medal?
Have you, or do you know someone who has had diabetes for 50 years? Or even 60 or 70 years? If so, why not nominate them for a Diabetes UK Medal? You can also nominate yourself. Diabetes UK Supporter Services is presenting a selection of medals under the title of the charity's founding fathers in recognition of the challenges that people living with diabetes for more than 50, 60 or 70 years have faced.

DRSI Launches The First And Only Diabetes Energy Formula Specifically Created For Diabetics To Counter Their No. 1 Complaint: Fatigue
Diabetica Research Solutions, Inc. (DRSI) http://www.drsirestoreenergy.com: Diabetes is a disease of energy currently affecting 24 million people who have been diagnosed and approximately 55 million who are in a pre-diabetic condition. For so many of these people with diabetes, particularly those with type 2 diabetes, persistent fatigue is a constant complaint.

The Endocrine Society Responds To Recent Insulin Glargine (Lantus(R)) Study With Recommendations For Patients And Physicians
Five articles recently posted online in the medical journal Diabetologia studied the possible connection between the use of insulin glargine (Lantus®) and the development of cancer. While one of these studies suggested an increased risk of cancer, the other four did not come to the same conclusion. Taken together, the results of all these studies do not conclusively show that insulin glargine causes cancer or is otherwise harmful to a patient's overall health.

"Jumping Gene" Diminishes The Effect Of A New Type 2 Diabetes Risk Gene
Research led by the German Institute of Human Nutrition (DIfE) has identified a new gene associated with diabetes, together with a mechanism that makes obese mice less susceptible to diabetes. A genomic fragment that occurs naturally in some mouse strains diminishes the activity of the risk gene Zfp69. The researchers also found that the corresponding human gene (ZNF642) is especially active in overweight individuals with diabetes.

Have Your Say On Diabetes Care In Scotland
The Scottish Government has launched Better Diabetes Care - a consultation to improve diabetes care over the next three years - and Diabetes UK Scotland is encouraging everyone affected by diabetes to take part. Diabetes UK Scotland is consulting widely and is talking and listening to people affected by diabetes about their experiences of diabetes care and their priorities for the future.

Joint Replacement Patients With Diabetes Greatly Benefit From Controlled Glucose
Diabetics undergoing total joint replacement often are at a higher risk of experiencing complications after surgery due to various pre-existing health conditions. According to a new study published in the July 2009 issue of The Journal of Bone and Joint Surgery (JBJS), those complications are less likely to occur when a diabetic patient has glucose levels under control.

Teenagers Show The Government How To Help Tackle Diabetes And Cancer, UK
A group of 15-16 year old students have been reporting directly to the UK government, (Tuesday 30th June), on their proposals for how nanotechnology could be used to help meet the future needs of the healthcare sector.

Heatwave Advice For Diabetics
Experts are predicting record-breaking temperatures this week, so it's important to take precautions to ensure that your diabetes remains well-controlled in this extreme weather. Long periods of inactivity in the sun can affect diabetes control, making blood glucose levels higher than usual. On the flipside, insulin will be absorbed more quickly from the injection site in hot weather and this increases the risk of hypos.

Diabetes UK's Measure Up Roadshow Is A Success
Diabetes UK has so far encouraged more than 10,000 people in the UK to measure their waists and find out if they are at risk of developing Type 2 diabetes with its national Measure Up Roadshow which kicked off on June 3. The Measure Up Roadshow is touring the country until December in a bid to help people find out more about Type 2 diabetes and its risk factors.

Diabetes Specialists Call For Drug Regulators To Step In To Clarify Lantus Concerns, UK
BRITAIN'S top diabetes specialists added their weight to calls for European drug regulatory bodies to launch an urgent investigation into the popular insulin treatment glargine (Lantus). The move by the Association of British Clinical Diabetologists (ABCD) follows this week's publication of four studies, which raise possible concern about an increased risk of the development of cancer in people who use this long-acting insulin therapy.

Two Thirds Of People With Diabetes Not Receiving Vital Health Checks, UK
The latest National Diabetes Audit has revealed that 60 per cent of people with diabetes in England do not receive all of their vital annual health checks including blood glucose, blood pressure and eye tests.

Safe And Successful Fertility Treatment Possible In Women With Cystic Fibrosis
Women with cystic fibrosis can have fertility treatment to help them have babies without any long-term adverse effects on either themselves or their children, according to new research presented at the 25th annual meeting of the European Society of Human Reproduction and Embryology in Amsterdam. Until relatively recently, cystic fibrosis (CF) was a death sentence and most people with the disease died by the time they reached their teenage years.

Joint Replacement Patients With Diabetes Greatly Benefit From Controlled Glucose
Diabetics undergoing total joint replacement often are at a higher risk of experiencing complications after surgery due to various pre-existing health conditions. According to a new study published in the July 2009 issue of The Journal of Bone and Joint Surgery (JBJS), those complications are less likely to occur when a diabetic patient has glucose levels under control.

Examining Dietary Influences Of Liver Disease
Diets high in protein and cholesterol are associated with a higher risk of hospitalization or death due to cirrhosis or liver cancer, while diets high in carbohydrates are associated with a lower risk. These findings are in the July issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). The article is also available online at Wiley Interscience.

"Jumping Gene" Diminishes The Effect Of A New Type 2 Diabetes Risk Gene
Research led by the German Institute of Human Nutrition (DIfE) has identified a new gene associated with diabetes, together with a mechanism that makes obese mice less susceptible to diabetes. A genomic fragment that occurs naturally in some mouse strains diminishes the activity of the risk gene Zfp69. The researchers also found that the corresponding human gene (ZNF642) is especially active in overweight individuals with diabetes.

Two Thirds Of People With Diabetes Not Receiving Vital Health Checks, UK
The latest National Diabetes Audit has revealed that 60 per cent of people with diabetes in England do not receive all of their vital annual health checks including blood glucose, blood pressure and eye tests.

Heatwave Advice For Diabetics
Experts are predicting record-breaking temperatures this week, so it's important to take precautions to ensure that your diabetes remains well-controlled in this extreme weather. Long periods of inactivity in the sun can affect diabetes control, making blood glucose levels higher than usual. On the flipside, insulin will be absorbed more quickly from the injection site in hot weather and this increases the risk of hypos.

Diabetes UK Reaches Twitter Milestone
Diabetes UK has just reached the 1,000 follower mark on Twitter, the social networking and micro-blogging site that allows its users to send and receive each other's updates, or 'tweets'. The charity, present on Twitter since October 2008, is finding that the service is proving to be an invaluable way of communicating directly with people with diabetes and of raising the awareness of the condition and its complications.

Lap-Band Weight-Loss Surgery Can Reverse Metabolic Syndrome In Obese Teens
A new study of obese adolescents has shown that laparoscopic gastric banding surgery -- the "Lap-Band" procedure -- not only helps them achieve significant weight loss but can also improve and even reverse metabolic syndrome, reducing their risk for cardiovascular disease and diabetes.

Takeda Receives FDA Complete Response Letter For Alogliptin, An Investigational Treatment For Type 2 Diabetes
Takeda Pharmaceutical Company Limited ("Takeda") announced that Takeda Global Research & Development Center, Inc., a wholly owned United States (U.S.) subsidiary received on June 26 (U.S. time) a complete response letter from the U.S. Food and Drug Administration (FDA) regarding the Company's New Drug Application (NDA) for alogliptin, a selective dipeptidyl peptidase IV (DPP-4) inhibitor under investigation for the treatment of type 2 diabetes as an adjunct to diet and exercise.

Heatwave Advice For Diabetics
Experts are predicting record-breaking temperatures this week, so it's important to take precautions to ensure that your diabetes remains well-controlled in this extreme weather. Long periods of inactivity in the sun can affect diabetes control, making blood glucose levels higher than usual. On the flipside, insulin will be absorbed more quickly from the injection site in hot weather and this increases the risk of hypos.

American Diabetes Association Related To Studies Published In Diabetelogia Suggesting Possible Link Between Insulin Glargine And Cancer
Diabetelogia, the journal of the European Association for the Study of Diabetes (EASD), published a series of research papers today examining a possible link between insulin glargine (brand name, Lantus) and cancer. Findings from these research papers are conflicting and inconclusive, and the American Diabetes Association cautions against over-reaction until more information is available.

PPD Confirms Takeda Receives FDA Complete Response For Alogliptin
PPD, Inc. (NASDAQ: PPDI) today announced that Takeda Pharmaceutical Company Limited issued a news release reporting that Takeda Global Research & Development Center, Inc., its wholly-owned U.S. subsidiary, has received a complete response letter from the U.S. Food and Drug Administration (FDA) regarding its new drug application (NDA) for alogliptin.

CHMP Recommends 'Januvia(R)'(sitagliptin), From MSD, For Restricted First Line Use In European Union
Merck & Co., Inc. (Whitehouse Station, N.J., U.S.A.), which operates in many countries as Merck Sharp & Dohme (MSD), has received a positive opinion from the European Medicines Agency's (EMEA) Committee for Medicinal Products for Human Use (CHMP) recommending restricted first line use of 'Januvia' (sitagliptin) for the treatment of type 2 diabetes.

The American Diabetes Association Celebrates The Recognition Of Gary Branham And John Griffin
The American Diabetes Association, the nation's leading health organization in the fight to stop diabetes, is pleased to announce that the National Employment Lawyers Association has honored Gary Branham, who successfully fought discrimination based on diabetes, as one of three "Workplace Heroes & Heroines." The award honors those who have made a difference in the evolution of employee rights, and advancing equality and justice in the American workplace during the past twenty years.

Diabetes: It's Connection To Oral Health
According to the American Diabetes Association, nearly 24 million people have diabetes. Of that number, unfortunately, 5.7 million people are unaware that they have the disease. Diabetes can affect multiple parts of the body, including the kidneys, nerves, heart and even the mouth.

Pre-Diabetes Costs Nation $25 Billion Annually In Extra Medical Care, New Data Show
One of every four American adults suffers from a silent condition known as pre-diabetes at a cost of more than $25 billion a year in increased medical costs, according to new data published today. And among the 180,000 pregnant women diagnosed with gestational diabetes, health care costs attributed to the condition are estimated at $623 million a year, a companion study showed.

Self-Monitoring And POC Diabetes Tests Reveal Potential For Significant Growth, Boosting The European Diabetes Diagnostics Market
The European diabetes diagnostics market is poised for expansion with segments such as self-monitoring and point-of-care (POC) tests offering tremendous growth potential. Heightened efforts to generate awareness about diabetes and related diagnostic tests are a key driver in market development. For instance, limited awareness about HbA1C tests is restraining the laboratory market. However, this challenge will be curtailed with more education about the test.

Spherix Announces Positive Phase 2 Study Results
Spherix Incorporated (Nasdaq CM: SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, announced positive preliminary results from a Phase 2 clinical trial of its novel compound, Naturlose(R) (D-tagatose), in the treatment and management of Type 2 diabetes. The Phase 2 trial is expected to be completed in early 2010.

Diabetes Week 2009 - A Great Success, UK
Diabetes UK would like to say a huge 'thank you' to everyone who helped to make this year's Diabetes Week such a great success - we could not have done it without you. Throughout the week our volunteers, supporters and staff have been busy raising funds and diabetes awareness. Of the thousands of events that went on across the country, here are just a few of the Diabetes Week highlights.

Another JDRF Partner Moves Research Forward With Collaboration Agreement For Diabetes Treatment
The Juvenile Diabetes Research Foundation said recently that for the fourth time in 18 months, one of its biotech partners has signed a collaboration agreement with a large pharmaceutical company to move research on type 1 diabetes into the final phases of trials.

Spherix Announces Positive Phase 2 Study Results
Spherix Incorporated (Nasdaq CM: SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, announced positive preliminary results from a Phase 2 clinical trial of its novel compound, Naturlose(R) (D-tagatose), in the treatment and management of Type 2 diabetes. The Phase 2 trial is expected to be completed in early 2010.

Volunteer Achievement Awards 2009 - Nominations Needed, UK
For a fifth consecutive year Diabetes UK will be running its Volunteer Achievement Awards to celebrate and recognise the important work all its volunteers do. Awards can be given to individuals or groups. Nominations are welcome from volunteers, voluntary groups, healthcare professionals and Diabetes UK staff. Any Diabetes UK volunteer can be nominated for an award, and volunteers are also welcome to nominate themselves.

Innocoll Announces Provisional Findings From Its Three Phase 2 Clinical Trials Investigating CollaRx(R) GENTAMICIN TOPICAL
Innocoll, Inc., a privately-held biopharmaceutical company, announced positive provisional findings from its three phase 2 clinical trials sponsored by its wholly owned subsidiary, Innocoll Technologies Ltd, to investigate CollaRx(R) GENTAMICIN TOPICAL for the treatment and prevention of infection in diabetic foot ulcers. Chronic ulcerations such as diabetic foot ulcers are often colonized or contaminated with bacterial pathogens that can prevent ulcers from healing.

A Handful Of Peanuts Will Do You Good, Says British Heart Foundation
In response to a study published in The Journal of Nutrition (1) which showed how eating peanuts reduced the risk of heart attack in women with type two diabetes, British Heart Foundation (BHF) cardiac nurse Ellen Mason said: "It is beneficial to include nuts in our diets as they are low in the saturated fats that raise our cholesterol.

Diabetes: It's Connection To Oral Health
According to the American Diabetes Association, nearly 24 million people have diabetes. Of that number, unfortunately, 5.7 million people are unaware that they have the disease. Diabetes can affect multiple parts of the body, including the kidneys, nerves, heart and even the mouth.

Patients, Caregivers Can Learn To Manage Diabetes At Rite Aid Clinics June 23, 25
Select Rite Aid stores nationwide will host Diabetes Solutions Days on June 23 and 25 offering patients living with diabetes valuable health screenings and self-management solutions. Caregivers and patients alike can benefit from this free chance to get professional advice on the symptoms and treatments for diabetes as well as watching hands-on demonstrations. The free events and store locations are listed online based on zip code at

GW Expands Cannabinoid Research In The Field Of Diabetes And Metabolic Disease
"GW Metabolic Research Laboratory" established in conjunction with Professor Cawthorne and the Clore Laboratory, University of Buckingham Porton Down, UK, 16 June 2009: GW Pharmaceuticals plc (GWP:AIM) announces that it has entered into an exclusive strategic alliance with Professor Mike Cawthorne and the Clore Laboratory, University of Buckingham, focusing on the research of cannabinoids, and other phytomedicines, in the field of type 2 diabetes and metabolic disease.

Patients, Caregivers Can Learn To Manage Diabetes At Rite Aid Clinics June 23, 25
Select Rite Aid stores nationwide will host Diabetes Solutions Days on June 23 and 25 offering patients living with diabetes valuable health screenings and self-management solutions. Caregivers and patients alike can benefit from this free chance to get professional advice on the symptoms and treatments for diabetes as well as watching hands-on demonstrations. The free events and store locations are listed online based on zip code at

Health Research Agencies Form Global Alliance To Curb Humanity's Most Fatal Diseases
Six of the world's foremost health agencies, collectively managing an estimated 80% of all public health research funding, today announced formation of a landmark alliance to collaborate in the critical battle against chronic, non-communicable diseases: cardiovascular diseases (mainly heart disease and stroke), several cancers, chronic respiratory conditions, and type 2 diabetes.

Diabetes Amputees Converge On London's O2 Arena To Campaign For Better Foot Services
Diabetes UK is today bringing together 100 people, including 20 diabetes amputees, at the 'Body Worlds and Mirror of Time' exhibition at London's O2 Arena for a photo call to highlight the fact that diabetes causes 100 amputations a week in the UK. We are calling on hospitals and primary care organisations to adopt the recommendations set out in a new Diabetes UK/NHS Diabetes report, 'Putting feet first'.

The Battle For CRTC2: How Obesity Increases The Risk For Diabetes
Obesity is probably the most important factor in the development of insulin resistance, but science's understanding of the chain of events is still spotty. Now, researchers at the Salk Institute for Biological Studies have filled in the gap and identified the missing link between the two. Their findings, to be published in the June 21, 2009 advance online edition of the journal Nature, explain how obesity sets the stage for diabetes and why thin people can become insulin-resistant.

Another JDRF Partner Moves Research Forward With Collaboration Agreement For Diabetes Treatment
The Juvenile Diabetes Research Foundation said recently that for the fourth time in 18 months, one of its biotech partners has signed a collaboration agreement with a large pharmaceutical company to move research on type 1 diabetes into the final phases of trials.

Diabetes Experts Sound Caution Over Extended Role Of New Drugs, UK
MEDICAL experts have cautioned against indiscriminate use of new classes of medication for Britain's increasing number of people with diabetes - saying the drug advances needed "careful adoption" to meet their full treatment potential. The Association of British Clinical Diabetologists (ABCD) explored the safety and effectiveness of one new therapy in particular - exenatide - as part of a unique research project.

Diabetes UK Showcases User Involvement Initiative At Healthcare Innovation Expo
Diabetes UK will attend the prestigious Innovation Expo at London's ExCeL on 18 to 19 June. In June 2008, Lord Darzi published the Next Stage Review which identified the need to accelerate the adoption and diffusion of innovation across the NHS. As a result, the Expo will help encourage and inspire delegates who have influence in the NHS to interact with the latest innovative thinking, evidence and best practice.

Henry Ford Health System Adopts Healthy Interactions Conversation Map(R) Education Program As Standard Curriculum In Diabetes Education
Henry Ford Health System, one of the nation's top rated health systems and recognized visionaries in offering quality care, formally announced its adoption of Healthy Interactions U.S. Diabetes Conversation Map® education program in its diabetes education curriculum, proclaiming them to demonstrate increased effectiveness in helping patients with diabetes live with their condition.

GW Expands Cannabinoid Research In The Field Of Diabetes And Metabolic Disease
"GW Metabolic Research Laboratory" established in conjunction with Professor Cawthorne and the Clore Laboratory, University of Buckingham Porton Down, UK, 16 June 2009: GW Pharmaceuticals plc (GWP:AIM) announces that it has entered into an exclusive strategic alliance with Professor Mike Cawthorne and the Clore Laboratory, University of Buckingham, focusing on the research of cannabinoids, and other phytomedicines, in the field of type 2 diabetes and metabolic disease.

Rosiglitazone Does Not Harm Bone Healing If Combined With Metformin In Rats
Taking the diabetes medications metformin and rosiglitazone together reverses the adverse effects on bone of rosiglitazone treatment alone in an experimental model, according to a new study done in rats. The results were presented at The Endocrine Society's 91st Annual Meeting in Washington, D.C.

Abbott's TRILIPIX® (fenofibric Acid) In Combination With Rosuvastatin Calcium Helps Patients With Mixed Dyslipidemia And Type 2 Diabetes Meet Amer
Abbott's (NYSE: ABT) TRILIPIX® (fenofibric acid) delayed-release capsules in combination with rosuvastatin calcium achieved individual and combined lipid targets in patients with mixed dyslipidemia and type 2 diabetes. In these patients, the combination of TRILIPIX and rosuvastatin helped up to three times more patients simultaneously reach all three key lipid targets HDL, triglycerides and LDL than the pre-determined monotherapy.

National Council On Aging And Medicare Diabetes Screening Project Launch New Program To Educate Seniors About Medicare's Benefits For Diabetes
At a meeting sponsored by the National Council on Aging (NCOA) and the Medicare Diabetes Screening Project (MDSP), former Senate Majority Leader Tom Daschle, experts in diabetes research and education, and representatives of senior-serving organizations from a four-state area gathered in Washington, DC to draw attention to the need for increased screening for diabetes among older adults ages 65 and older insured by Medicare.

Yale Researchers Suggests Gene Inhibition May Help Normalize Type 2 Diabetes
In research that could lead to new approaches for the treatment of type 2 diabetes, a Yale School of Medicine team has found that suppressing a liver enzyme that induces glucose production helped diminish the symptoms of the disease in a rat model - reducing blood glucose concentrations, decreasing rates of glucose production in the liver, and improving insulin sensitivity. Decreasing expression of the gene, Sirtuin 1, also lowered total cholesterol levels.

Diabetes UK Showcases User Involvement Initiative At Healthcare Innovation Expo
Diabetes UK will attend the prestigious Innovation Expo at London's ExCeL on 18 to 19 June. In June 2008, Lord Darzi published the Next Stage Review which identified the need to accelerate the adoption and diffusion of innovation across the NHS. As a result, the Expo will help encourage and inspire delegates who have influence in the NHS to interact with the latest innovative thinking, evidence and best practice.

Diabetes UK Showcases User Involvement Initiative At Healthcare Innovation Expo
Diabetes UK will attend the prestigious Innovation Expo at London's ExCeL on 18 to 19 June. In June 2008, Lord Darzi published the Next Stage Review which identified the need to accelerate the adoption and diffusion of innovation across the NHS. As a result, the Expo will help encourage and inspire delegates who have influence in the NHS to interact with the latest innovative thinking, evidence and best practice.

Temple Podiatry Receives NIH Grant To Develop Personalized, Visual Diabetes Education Program
Loss of feeling in the feet is a common complication of diabetes, so it's critical that those with the disease wear shoes that fit properly and check their feet often for cuts or sores. Left untreated, a diabetic's foot wound can lead to a serious infection or even require amputation. With diabetes rates steadily increasing, the issue is emerging as a major public health problem.

Diabetes Amputees Converge On London's O2 Arena To Campaign For Better Foot Services
Diabetes UK is today bringing together 100 people, including 20 diabetes amputees, at the 'Body Worlds and Mirror of Time' exhibition at London's O2 Arena for a photo call to highlight the fact that diabetes causes 100 amputations a week in the UK. We are calling on hospitals and primary care organisations to adopt the recommendations set out in a new Diabetes UK/NHS Diabetes report, 'Putting feet first'.

Why Smoking Increases The Risk Of Heart Disease And Strokes
Researchers at Charles Drew University of Medicine and Science in Los Angeles and Western University of Health Sciences in Pomona have discovered a reason why smoking increases the risk of heart disease and strokes. The study, which was presented at The Endocrine Society's 91st annual meeting in Washington, D.C., found that nicotine in cigarettes promotes insulin resistance, a pre-diabetic condition that raises blood sugar levels higher than normal.

New Diabetes Device Waves Good-Bye To Paper Log Books
Roche Diagnostics announces launch of new Accu-Chek Smart Pix diabetes management system for consumers. Traditionally, Accu-Chek Smart Pix has been an information management tool used by healthcare specialists in clinics, but now people with diabetes can benefit from this advanced technology for home use. With this brand new device, manual log books become a thing of the past, and patients remain fully in control of their diabetes at all times.

Health Research Agencies Form Global Alliance To Curb Humanity's Most Fatal Diseases
Six of the world's foremost health agencies, collectively managing an estimated 80% of all public health research funding, today announced formation of a landmark alliance to collaborate in the critical battle against chronic, non-communicable diseases: cardiovascular diseases (mainly heart disease and stroke), several cancers, chronic respiratory conditions, and type 2 diabetes.

Abbott's TRILIPIX® (fenofibric Acid) In Combination With Rosuvastatin Calcium Helps Patients With Mixed Dyslipidemia And Type 2 Diabetes Meet Amer
Abbott's (NYSE: ABT) TRILIPIX® (fenofibric acid) delayed-release capsules in combination with rosuvastatin calcium achieved individual and combined lipid targets in patients with mixed dyslipidemia and type 2 diabetes. In these patients, the combination of TRILIPIX and rosuvastatin helped up to three times more patients simultaneously reach all three key lipid targets HDL, triglycerides and LDL than the pre-determined monotherapy.

Screening For Left Ventricular Dysfunction May Have Less Value Than Thought
The value and cost-effectiveness of screening for left ventricular (LV) dysfunction remains unclear, particularly since specific, evidence-based treatments are not available for the majority of patients with preserved systolic dysfunction, reports a study in the June issue of the Journal of Cardiac Failure, published by Elsevier.

Diabetes Amputees Converge On London's O2 Arena To Campaign For Better Foot Services
Diabetes UK is today bringing together 100 people, including 20 diabetes amputees, at the 'Body Worlds and Mirror of Time' exhibition at London's O2 Arena for a photo call to highlight the fact that diabetes causes 100 amputations a week in the UK. We are calling on hospitals and primary care organisations to adopt the recommendations set out in a new Diabetes UK/NHS Diabetes report, 'Putting feet first'.

InteKrin Therapeutics Announces INT131 Phase 2a Results At The 2009 American Diabetes Association Annual Meeting
InteKrin Therapeutics Inc presented Phase 2a clinical study results at the American Diabetes Association annual meeting in New Orleans demonstrating that once a day oral treatment with INT131 provides anti-diabetic efficacy consistent with maximal dose thiazolidinedione (TZD) therapy but with less hematocrit reduction and weight gain.